Mirae Asset Global Investments Co., Ltd. Rhythm Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,820 shares of RYTM stock, worth $97,552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,820Holding current value
$97,552% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding RYTM
# of Institutions
178Shares Held
69.1MCall Options Held
467KPut Options Held
224K-
Primecap Management CO Pasadena, CA7.31MShares$392 Million0.22% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$361 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$343 Million3.49% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$326 Million3.77% of portfolio
-
Goldman Sachs Group Inc New York, NY5.29MShares$283 Million0.04% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.99B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...